Menu Close

PFS Investments Inc. Acquires 7,025 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

PFS Investments Inc. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 11.2% in the first quarter, Holdings Channel reports. The fund owned 69,724 shares of the healthcare conglomerate’s stock after purchasing an additional 7,025 shares during the quarter. PFS Investments Inc.’s holdings in UnitedHealth Group were worth $35,557,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. NorthCrest Asset Manangement LLC lifted its stake in UnitedHealth Group by 9.5% in the first quarter. NorthCrest Asset Manangement LLC now owns 518 shares of the healthcare conglomerate’s stock worth $264,000 after purchasing an additional 45 shares during the last quarter. NewEdge Advisors LLC lifted its stake in UnitedHealth Group by 10.4% in the first quarter. NewEdge Advisors LLC now owns 125,780 shares of the healthcare conglomerate’s stock worth $64,144,000 after purchasing an additional 11,880 shares during the last quarter. Domani Wealth LLC lifted its stake in UnitedHealth Group by 0.7% in the first quarter. Domani Wealth LLC now owns 3,542 shares of the healthcare conglomerate’s stock worth $1,806,000 after purchasing an additional 25 shares during the last quarter. Stratos Wealth Partners LTD. increased its position in shares of UnitedHealth Group by 44.0% during the first quarter. Stratos Wealth Partners LTD. now owns 17,711 shares of the healthcare conglomerate’s stock worth $9,032,000 after acquiring an additional 5,414 shares during the period. Finally, Salvus Wealth Management LLC increased its position in shares of UnitedHealth Group by 23.5% during the first quarter. Salvus Wealth Management LLC now owns 782 shares of the healthcare conglomerate’s stock worth $399,000 after acquiring an additional 149 shares during the period. Institutional investors own 87.25% of the company’s stock.

UnitedHealth Group Trading Down 0.6 %

NYSE UNH opened at $524.34 on Friday. The company’s fifty day simple moving average is $528.73 and its 200-day simple moving average is $509.85. UnitedHealth Group Incorporated has a 52 week low of $383.12 and a 52 week high of $553.29. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.60. The stock has a market cap of $490.46 billion, a P/E ratio of 27.38, a PEG ratio of 1.62 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. During the same period in the previous year, the company posted $4.70 earnings per share. The business’s revenue for the quarter was up 12.6% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 20th. Investors of record on Monday, September 12th will be issued a $1.65 dividend. The ex-dividend date is Friday, September 9th. This represents a $6.60 annualized dividend and a yield of 1.26%. UnitedHealth Group’s dividend payout ratio is presently 34.46%.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,273 shares of the business’s stock in a transaction on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total transaction of $635,227.00. Following the sale, the executive vice president now owns 8,104 shares of the company’s stock, valued at approximately $4,043,896. The disclosure for this sale can be found here. Insiders have sold 140,324 shares of company stock valued at $75,086,185 over the last ninety days. Corporate insiders own 0.40% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. SVB Leerink lifted their price objective on shares of UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a research note on Monday, July 18th. Mizuho boosted their target price on shares of UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, August 10th. Sanford C. Bernstein cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 target price for the company. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Finally, Loop Capital started coverage on shares of UnitedHealth Group in a report on Thursday, June 16th. They issued a “buy” rating and a $575.00 target price on the stock. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $585.65.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.